Rialto

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Liver cirrhosis1 trial

Phase

• Phase 22 trials
• Phase 11 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline3 trials

Running trials

• Recruiting

  A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

  NCT07358546· Phase 1· GlaxoSmithKline· Source

  Contact: Zeid Kayali (principal investigator)

• Recruiting

  A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

  NCT06920043· Phase 2· GlaxoSmithKline· Source

  Contact: Zeid Kayali (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Liver cirrhosis1 recruiting

Closed trials

• Completed

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· Phase 2· GlaxoSmithKline· Source